Light therapy restores immune balance in rare skin cancer
NCT ID NCT07235813
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 16 people with mycosis fungoides, a rare skin lymphoma, and 16 healthy volunteers. Researchers measured a protein called IL-35, which can suppress the immune system, in blood and skin samples before and after phototherapy (light treatment). They found that IL-35 levels were much higher in patients than in healthy people, but dropped back to normal after phototherapy. The results suggest that phototherapy may help restore immune balance, and IL-35 could be used to track how well treatment is working.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOSIS FUNGOIDES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kasr El Aini Hospital
Cairo, English (English), 11511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin gel targets immune signals in rare lymphoma
- Could an ALS drug clear the fog of chemo brain?
- Combination therapy aims to boost response in rare skin cancers
- Supercharged immune cells aim to stop lymphoma comeback
- Massive T-Cell lymphoma database aims to unlock new insights
- Promising skin cancer trial pulled before it even started